PHILADELPHIA Twenty-two of the nation's most innovative young researchers were named Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts today. The Scholars join a prestigious community that includes Nobel Prize winners, MacArthur Fellows, and recipients of the Albert Lasker Medical Research Award.
"During these challenging budgetary times when traditional sources of funding are becoming even harder for scientists to obtain, we are proud to back our country's most promising scientists," said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts. "This funding comes at points in the Scholars' professional lives when they often are the most innovative. While this program is a bold investment for us, it has paid incalculable dividends due to our Scholars' record of producing groundbreaking research." The new class of scholars is exploring a range of human health issues from antibiotic-resistant infections to liver disease and cancer.
Launched in 1985, the Pew Scholars Program in the Biomedical Sciences identifies and invests in talented researchers in medicine or biomedical sciences. In that time, over 500 Pew Scholars have received more than $130 million in funding. By backing them early in their careers, this program enables our most promising scientists to take calculated risks and follow unanticipated leads to advance human health. "Giving young scientists the means and the confidence to pursue outside-the-box research is vital to the advancement of biomedical science," said Craig C. Mello, Ph.D., a 1995 Pew Scholar and a 2006 Nobel Laureate in Physiology or Medicine. "The Pew Scholars Program in the Biomedical Sciences was a critical step in my career, and as Chair of the national advisory committee, and I am honored to welcome the 2012 awardees into a family of scientists eager to share ideas and to collaborate for years to come."
The program is rigorously competitive, and recipients receive $
|Contact: Nicolle Grayson|
Pew Health Group